InvestorsHub Logo
Followers 276
Posts 36029
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Friday, 12/06/2019 7:28:04 PM

Friday, December 06, 2019 7:28:04 PM

Post# of 2793
8K ~> license agreement for vosaroxin pursuant to which Sunesis is eligible to receive an upfront payment, up to $57.0 million in regulatory and commercial milestones, and double-digit royalties on future sales of vosaroxin.

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.